Join global thought leaders for a cutting-edge satellite meeting ahead of the 20th World Congress of Basic and Clinical Pharmacology 2026 (WCP2026) exploring the impact of cellular and extra-cellular mechanics on pharmacology of new and emerging drug treatments of inflammation fibrosis and metabolic disease.
Speakers
Emeritus Prof Clive Page
King's College London / Verona Pharma
Development of novel drugs for the treatment of respiratory diseases.
Dr Danilo Tagle
National Institutes of Health (NIH), USA
Advancing MPS and combinatorial NAMs towards regulatory acceptance and global utility.
A/Prof Thai Tran
National University of Singapore, Singapore
Targeting CD151 at Fibrosis–Inflammation Interface in Respiratory Disease
A/Prof Garron Dodd
University of Melbourne, Australia
Targeting Brain Fibrosis for the Treatment of Obesity and Diabetes.
Prof Peter Crack
University of Melbourne, Australia
The impact of neuroinflammation in acute brain injury.
Prof Gilberto DeNucci
University of São Paulo (USP), Brasil
Potential roles of novel endogenous catecholamines in inflammation.
Dr Tara Sutherland
University of Aberdeen, UK
Illuminating matrix remodelling: myeloid-ECM dynamics during allergic airway pathology
Dr Rhiannon Werder
Murdoch Children’s Research Institute, Australia
Human iPSC-Derived Lung Models to Dissect Infection-Induced Inflammation and Fibrosis by Human-Tropic Pathogens